Explaining Sequencing

Aug 18, 2009

In this short video, John Nelson at GE Global Research explains why he and his colleagues are working toward a $1,000 genome, how sequencing can help medicine, and the ethical implications of sequencing a human genome.

Breaking News

Helix, Medical University of South Carolina Partner for Population Genomics Program
European Commission Objects to Illumina Pushing Through Grail Purchase, Mulls Restorative Actions
Forensic Genomics Firm Othram Raises $18M in Series B Round
Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx
Grail Gets NY State Department of Health Approval for Galleri Multicancer Test
Top Five Articles on GenomeWeb Last Week: Ginkgo Bioworks, Illumina, FDA, and More

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.

Explaining Sequencing

Helix, Medical University of South Carolina Partner for Population Genomics Program

European Commission Objects to Illumina Pushing Through Grail Purchase, Mulls Restorative Actions

Forensic Genomics Firm Othram Raises $18M in Series B Round

Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx

Grail Gets NY State Department of Health Approval for Galleri Multicancer Test

Top Five Articles on GenomeWeb Last Week: Ginkgo Bioworks, Illumina, FDA, and More

For Better Odds

Booster Decision Expected

Snipping HIV Out

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests

Ancient DNA Analysis Highlights Three Ancestral Populations in Japan

Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle

Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger

Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022